Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells

Breast cancer accounts for up to 10% of the newly diagnosed cancer cases worldwide, making it the most common cancer found in women. The use of superparamagnetic iron oxide nanoparticles (SPIONs) has been beneficial in the advancement of contrast agents and magnetic hyperthermia (MH) for the diagnos...

Descripción completa

Detalles Bibliográficos
Autores: Mekseriwattana, Wid, Guardia, Pablo, Torres Herrero, Beatriz, Fuente, Jesús M. de la, Kuhakarn, Chutima, Roig Serra, Anna, Katewongsa, Kanlaya Prapainop
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/269715
Acceso en línea:http://hdl.handle.net/10261/269715
https://api.elsevier.com/content/abstract/scopus_id/85128156627
Access Level:acceso abierto
Palabra clave:Iron-oxide nanoparticles
Particle-size
Citric-acid
Hyperthermia
id ES_c23c91cf96e02bda00a57b5b3383b6ae
oai_identifier_str oai:digital.csic.es:10261/269715
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
title Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
spellingShingle Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
Mekseriwattana, Wid
Iron-oxide nanoparticles
Particle-size
Citric-acid
Hyperthermia
title_short Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
title_full Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
title_fullStr Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
title_full_unstemmed Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
title_sort Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells
dc.creator.none.fl_str_mv Mekseriwattana, Wid
Guardia, Pablo
Torres Herrero, Beatriz
Fuente, Jesús M. de la
Kuhakarn, Chutima
Roig Serra, Anna
Katewongsa, Kanlaya Prapainop
author Mekseriwattana, Wid
author_facet Mekseriwattana, Wid
Guardia, Pablo
Torres Herrero, Beatriz
Fuente, Jesús M. de la
Kuhakarn, Chutima
Roig Serra, Anna
Katewongsa, Kanlaya Prapainop
author_role author
author2 Guardia, Pablo
Torres Herrero, Beatriz
Fuente, Jesús M. de la
Kuhakarn, Chutima
Roig Serra, Anna
Katewongsa, Kanlaya Prapainop
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Mahidol University
National Research Council of Thailand
Ministry of Higher Education, Science, Research and Innovation (Thailand)
Ministerio de Ciencia, Innovación y Universidades (España)
European Commission
Center of Excellence for Innovation in Chemistry (Thailand)
Ministerio de Ciencia, Innovación y Universidades (España)
Diputación General de Aragón
Agencia Estatal de Investigación (España)
Mekseriwattana, Wid [0000-0002-0966-6293]
Torres Herrero, Beatriz 0000-0003-4648-8972]
Kuhakarn, Chutima [0000-0003-4638-4356]
Roig Serra, Anna [0000-0001-6464-7573]
Katewongsa, Kanlaya Prapainop [0000-0001-6417-4921]
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
dc.subject.none.fl_str_mv Iron-oxide nanoparticles
Particle-size
Citric-acid
Hyperthermia
topic Iron-oxide nanoparticles
Particle-size
Citric-acid
Hyperthermia
description Breast cancer accounts for up to 10% of the newly diagnosed cancer cases worldwide, making it the most common cancer found in women. The use of superparamagnetic iron oxide nanoparticles (SPIONs) has been beneficial in the advancement of contrast agents and magnetic hyperthermia (MH) for the diagnosis and treatment of cancers. To achieve delivery of SPIONs to cancer cells, surface functionalization with specific ligands are required. Riboflavin carrier protein (RCP) has been identified as an alternative target for breast cancer cells. Here, we report a novel riboflavin (Rf)-based ligand that provides SPIONs with enhanced colloidal stability and high uptake potential in breast cancer cells. This is achieved by synthesizing an Rf-citrate ligand. The ligand was tested in a multicore SPION system, and affinity to RCP was assessed by isothermal titration calorimetry which showed a specific, entropy-driven binding. MRI and MH responses of the coated Rf-SPIONs were tested to evaluate the suitability of this system as a theranostic platform. Finally, interaction of the Rf-SPIONs with breast cancer cells was evaluated by in vitro cellular uptake in MCF-7 breast cancer cells. The overall characterization of the Rf-SPIONs highlighted the excellent performance of this platform for theranostic applications in breast cancer.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022
2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
Publisher's version
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/269715
https://api.elsevier.com/content/abstract/scopus_id/85128156627
url http://hdl.handle.net/10261/269715
https://api.elsevier.com/content/abstract/scopus_id/85128156627
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv #PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
info:eu-repo/grantAgreement/AEI//CEX2019-000917-S
info:eu-repo/grantAgreement/AEI//RyC2019-028414-I
Nanoscale Advances
The underlying dataset has been published as supplementary material of the article in the publisher platform at DOI 10.1039/d2na00015f
http://dx.doi.org/10.1039/d2na00015f

dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Royal Society of Chemistry (UK)
publisher.none.fl_str_mv Royal Society of Chemistry (UK)
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418648049811456
spelling Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cellsMekseriwattana, WidGuardia, PabloTorres Herrero, BeatrizFuente, Jesús M. de laKuhakarn, ChutimaRoig Serra, AnnaKatewongsa, Kanlaya PrapainopIron-oxide nanoparticlesParticle-sizeCitric-acidHyperthermiaBreast cancer accounts for up to 10% of the newly diagnosed cancer cases worldwide, making it the most common cancer found in women. The use of superparamagnetic iron oxide nanoparticles (SPIONs) has been beneficial in the advancement of contrast agents and magnetic hyperthermia (MH) for the diagnosis and treatment of cancers. To achieve delivery of SPIONs to cancer cells, surface functionalization with specific ligands are required. Riboflavin carrier protein (RCP) has been identified as an alternative target for breast cancer cells. Here, we report a novel riboflavin (Rf)-based ligand that provides SPIONs with enhanced colloidal stability and high uptake potential in breast cancer cells. This is achieved by synthesizing an Rf-citrate ligand. The ligand was tested in a multicore SPION system, and affinity to RCP was assessed by isothermal titration calorimetry which showed a specific, entropy-driven binding. MRI and MH responses of the coated Rf-SPIONs were tested to evaluate the suitability of this system as a theranostic platform. Finally, interaction of the Rf-SPIONs with breast cancer cells was evaluated by in vitro cellular uptake in MCF-7 breast cancer cells. The overall characterization of the Rf-SPIONs highlighted the excellent performance of this platform for theranostic applications in breast cancer.This project was supported by Mahidol University under a New Discovery and Frontier Research Grant to K. P. K. This project is funded by National Research Council of Thailand (NRCT) and Mahidol University: N42A650357. Partial support was also provided by a Central Instrument Facility (CIF) grant and the Center for Nanoimaging, Center of Excellence for Innovation in Chemistry (PERCH-CIC), Ministry of Higher Education, Science, Research and Innovation, Faculty of Science, Mahidol University. W. M. was supported by the Science Achievement Scholarship of Thailand. The authors would like to thank Associate Professor Nuttawee Niamsiri, Department of Biotechnology, Faculty of Science, Mahidol University, for the use of the Zetasizer instrument. This research was also funded by the Spanish Government, through the “Severo Ochoa” Programme for Centers of Excellence in R&D (FUNFUTURE, CEX2019-000917 S) and DGA, through the “Fondo Social Europeo” (DGA E15_20R). B. T. H. is grateful for a predoctoral fellowship FPU (FPU19/01311). P. G. acknowledges financial support from the Spanish government (MICIU) through the Ramon y Cajal research program (RyC2019-028414-I).Peer reviewedRoyal Society of Chemistry (UK)Mahidol UniversityNational Research Council of ThailandMinistry of Higher Education, Science, Research and Innovation (Thailand)Ministerio de Ciencia, Innovación y Universidades (España)European CommissionCenter of Excellence for Innovation in Chemistry (Thailand)Ministerio de Ciencia, Innovación y Universidades (España)Diputación General de AragónAgencia Estatal de Investigación (España)Mekseriwattana, Wid [0000-0002-0966-6293]Torres Herrero, Beatriz 0000-0003-4648-8972]Kuhakarn, Chutima [0000-0003-4638-4356]Roig Serra, Anna [0000-0001-6464-7573]Katewongsa, Kanlaya Prapainop [0000-0001-6417-4921]Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202220222022info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/269715https://api.elsevier.com/content/abstract/scopus_id/85128156627reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/AEI//CEX2019-000917-Sinfo:eu-repo/grantAgreement/AEI//RyC2019-028414-INanoscale AdvancesThe underlying dataset has been published as supplementary material of the article in the publisher platform at DOI 10.1039/d2na00015fhttp://dx.doi.org/10.1039/d2na00015fSíinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/2697152026-05-22T06:33:51Z
score 15,812429